Expression of PPAR-γ in adipose tissue of rats with polycystic ovary syndrome induced by DHEA

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 889-893

  Wang, Yu Xia ^a   Zhu, Wei Jie ^a   Xie, Bao Guo ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Adipocytes; Dehydroepiandrosterone; Peroxisome proliferator activated receptor ; Polycystic ovary syndrome

Indexed keywords

ADIPOSE TISSUE; ANIMALS; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HYPERANDROGENISM; INJECTIONS, SUBCUTANEOUS; POLYCYSTIC OVARY SYNDROME; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84893863495     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1895     Document Type: Article

References (29)

1. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC and Seeley RJ: A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med 17: 623-626, 2011.
2. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C and Mathis D: PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486: 549-553, 2012.
3. Sun K and Scherer PE: The PPARγ-FGF1 axis: an unexpected mediator of adipose tissue homeostasis. Cell Res 22: 1416-1418, 2012.
4. Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, Yu RT, Olefsky JM, Henry RR, Downes M and Evans RM: A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485: 391-394, 2012.
5. Tyagi S, Gupta P, Saini AS, Kaushal C and Sharma S: The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2: 236-240, 2011.
6. Svendsen PF, Christiansen M, Hedley PL, Nilas L, Pedersen SB and Madsbad S: Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 98: 235-241, 2012.
7. Dasgupta S, Sirisha P, Neelaveni K, Anuradha K, Sudhakar G and Reddy BM: Polymorphisms in the IRS-1 and PPAR-γ genes and their association with polycystic ovary syndrome among South Indian women. Gene 503: 140-146, 2012.
8. Saraf N, Sharma PK, Mondal SC, Garg VK and Singh AK: Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization. J Pharm Pharmacol 64: 161-171, 2012.
9. Amalfi S, Velez LM, Heber MF, Vighi S, Ferreira SR, Orozco AV, Pignataro O and Motta AB: Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PLoS One 7: e37658, 2012.
10. Lenarcik A, Bidzińska-Speichert B, Tworowska-Bardzińska U and Krȩpuła K: Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynol Pol 62: 129-133, 2011.
11. Abramovich D, Irusta G, Bas D, Cataldi NI, Parborell F and Tesone M: Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology 153: 3446-3456, 2012.
12. Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrøm V, Flyvbjerg A and Hermann AP: Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 155: 337-345, 2006.
13. Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A, Manase K and Kudo R: Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod 64: 157-162, 2001.
14. Rosenfield RL, Mortensen M, Wroblewski K, Littlejohn E and Ehrmann DA: Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod 26: 3138-3146, 2011.
15. Wang YX, Xie XM and Zhu WJ: Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications. J Huazhong Univ Sci Technolog Med Sci 30: 638-642, 2010.
16. Wang YX, Sun YY and Qiu HY: Expression of resistin mRNA in adipose tissue of rat model with polycystic ovarian syndrome and its implication. J Huazhong Univ Sci Technolog Med Sci 24: 621-624, 2004.
17. Knebel B, Lehr S, Janssen OE, Hahn S, Nitzgen U, Jacob S, Haas J, Muller-Wieland D and Kotzka J: Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome. Arch Physiol Biochem 118: 219-229, 2012.
18. Zhang H, Bi Y, Hu C, Lu W and Zhu D: Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: a meta-analysis of case-control studies. Gene 503: 12-17, 2012.
19. San-Millán JL and Escobar-Morreale HF: The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin Endocrinol (Oxf) 72: 383-392, 2010.
20. Brettenthaler N, De Geyter C, Huber PR and Keller U: Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89: 3835-3840, 2004.
21. Yildiz BO, Yarali H, Oguz H and Bayraktar M: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 2031-2036, 2003.
22. Brennan K, Huang A and Azziz R: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril 91: 1848-1852, 2009.
23. Kajita K, Ishizuka T, Mune T, Miura A, Ishizawa M, Kanoh Y, Kawai Y, Natsume Y and Yasuda K: Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. Endocrinology 144: 253-259, 2003.
24. Yogosawa S, Mizutani S, Ogawa Y and Izumi T: Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor γ and C/EBPα. Diabetes 62: 115-123, 2012.
25. Swaroop JJ, Rajarajeswari D and Naidu JN: Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian J Med Res 135: 127-130, 2012.
26. Wang F, Gao L, Gong B, Hu J, Li M, Guan Q and Zhao J: Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol. Can J Physiol Pharmacol 86: 465-471, 2008.
27. Sharma AK, Bharti S, Ojha S, Bhatia J, Kumar N, Ray R, Kumari S and Arya DS: Up-regulation of PPARγ, heat shock protein-27 and-72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr 106: 1713-1723, 2011.
28. Kim J, Sato M, Li Q, Lydon JP, Demayo FJ, Bagchi IC and Bagchi MK: Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice. Mol Cell Biol 28: 1770-1782, 2008.
29. Asrih M, Lerch R, Papageorgiou I, Pellieux C and Montessuit C: Differential regulation of stimulated glucose transport by free fatty acids and PPARα or-δ agonists in cardiac myocytes. Am J Physiol Endocrinol Metab 302: E872-E884, 2012.